Dermalux LED Phototherapy is a non-invasive and non-thermal skin treatment that uses specific wavelengths of light to stimulate various skin rejuvenation processes. This therapy is designed to address a variety of skin concerns.

Dermalux LED Phototherapy utilises light-emitting diodes (LEDs) that emit specific wavelengths of light, typically in the blue, red, and near-infrared spectrum. Each of these wavelengths has different effects on the skin. Phototherapy operates on the fundamental concept that all living cells have evolved to absorb and respond to light. Light, with its inherent energy, can exert a profound influence on our appearance, well-being, and performance when applied appropriately.

The underlying mechanism of action closely parallels the natural process of photosynthesis and is termed photobiomodulation. This process harnesses the body’s remarkable ability to heal itself, with light playing a pivotal role in this restorative journey.

During treatment, the skin is exposed to specific wavelengths or nanometers (nm) within both the visible (colour) and the invisible infrared portions of the light spectrum. The careful selection of these wavelengths is paramount to the effectiveness of LED therapy, as it dictates the degree to which light is absorbed. It transcends mere colour choice and becomes a crucial factor in the treatment’s success.

Blue Light

Key Function: Antibacterial

The 415nm blue wavelength is a well-established choice for eradicating the acne-causing bacteria and enhancing skin clarity, all while maintaining a gentle approach to skin care. Its potent antibacterial properties also impart a soothing influence, effectively reducing redness and inflammation.

Red Light

Key Function: Rejuvenation

At 633nm, the red wavelength supercharges cellular energy, expediting the repair and renewal processes. It amplifies collagen synthesis, augments hydration, and promotes enhanced circulation, effectively reversing the outward manifestations of aging. An ideal choice for rekindling vitality and radiance.

Near-Infrared Light

Key Function: Wound Healing

At 830nm, the near-infrared wavelength specifically addresses deeper skin cells, instigating the wound healing process, soothing redness and irritation, diminishing pigmentation, and fostering skin health. When combined with the Red 633nm wavelength, it offers advanced rejuvenation advantages.

We use The Tri-Wave MD which represents a groundbreaking leap in LED Phototherapy treatments, pushing the limits of medical LED technology and elevating clinical applications to a whole new level.

By harnessing the full potential of cutting-edge ceramic light technology, this FDA-certified and medically approved LED device offers unparalleled power and unmatched results across a broad spectrum of skin conditions.

The Tri-Wave MD sets a new standard for innovation that outperforms any other LED Phototherapy device available worldwide.

Dermalux LED Phototherapy can provide various benefits, including reduced acne breakouts, improved skin texture, minimised fine lines and wrinkles, enhanced skin tone and firmness, and a reduction in skin redness. It can also help accelerate the healing of wounds and skin injuries.

The Tri-Wave MD also offers the highest standard for Photodynamic Therapy (PDT), thanks to its extensive treatment capabilities covering the face, head, and body. It provides customisable energy delivery options in both joules and time, along with specialised PDT protocols utilising mono and polychromatic wavelengths. Its medical licenses encompass the treatment of Actinic Keratosis, Basal Cell Carcinoma, and Squamous Cell Carcinoma.

Photodynamic Therapy (PDT) is a non-invasive procedure approved for treating Non Melanoma Skin Cancers (NMSC). This method involves applying a photosensitiser prodrug topically and then using a light source to selectively eliminate abnormal or damaged cells and tissues.

While clinical protocols for these conditions are still evolving, growing evidence suggests that PDT can be beneficial for acne, more severe inflammatory conditions, and photodamage. The photosensitiser prodrug and the light source are harmless on their own. However, when exposed to the light source, the prodrug triggers a free radical (ROS) reaction, which selectively destroys the targeted cells.

PDT is a widely accepted therapeutic option, serving as an alternative to surgical procedures for specific dermatological concerns. Patients tend to be highly satisfied with the treatment, experience minimal downtime, and achieve excellent cosmetic results.

Key indications for PDT with well-established treatment outcomes, backed by independent clinical data, include:

– Actinic Keratosis (AK)

– Non-hyperkeratotic Keratosis

– Bowens disease

– Superficial Basal Cell Carcinoma (BCC)

–   Superficial Squamous Cell Carcinoma (SCC)

A typical photodynamic therapy (PDT) procedure involves applying a topical chemical compound known as 5-Aminolevulinic Acid (5-ALA) or its methylated ester, Methyl Aminolevulinate (MAL), to the affected area. The 5-ALA penetrates the outermost skin layer, known as the stratum corneum, and is selectively absorbed by cells that are damaged by exposure to UV radiation, non-melanoma skin cancer cells, and the pilosebaceous units of the skin. Within the skin, 5-ALA is converted into its active form, a natural intracellular photosensitiser called Protoporphyrin IX (PpIX).

Protoporphyrin IX is a substance that is naturally present in small amounts in all living cells and serves as a precursor to heme, a component of hemoglobin that gives blood its characteristic red color and facilitates oxygen transport throughout the body. In the context of PDT, PpIX accumulates in damaged and rapidly proliferating epidermal cells, as well as in melanin, blood vessels, and sebaceous glands. Damaged cells naturally produce more PpIX, and excessive levels of PpIX can lead to photosensitivity of the skin.

After a specified accumulation period, typically lasting up to 3 hours, the affected area is exposed to a specific wavelength of light. This light irradiation triggers the oxidation of PpIX through a process called photobleaching. During this process, singlet oxygen and free radicals are generated, resulting in apoptosis, which is selective cell death. It’s important to note that only the targeted cells and tissues are affected during this process, but the skin may remain photosensitive for up to 48 hours after treatment.

As a result of the PDT treatment, the damaged cells shed, allowing new healthy cells to regenerate and replace them.

The activation of photosensitiser prodrugs can be achieved using either red or blue light, depending on the specific medical indication.

One of the advantages of Dermalux LED Phototherapy is that it is non-invasive and painless. It does not require any downtime, and patients can return to their normal activities immediately after a treatment session.

A typical Dermalux LED Phototherapy session can last anywhere from 20 to 30 minutes. For best results, a series of treatments are recommended, with maintenance sessions as needed to sustain the benefits over time. Our skin specialists will asses you skin condition and cosmetic goals and recommend a suitable treatment plan.

LED phototherapy is considered safe for most skin types, and side effects are minimal. However, it’s important to protect your eyes from the LED light during treatment. We provide goggles to wear throughout your treatment.